# Brendan D. Curti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brendan-d-curti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,380 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 54 |
| i10-index | 146 |
| Last Known Institution | Providence Portland Medical Center |
| OpenAlex ID | https://openalex.org/A5029588412 |
| ORCID iD | https://orcid.org/0000-0003-3948-2708 |
| Works | 410 |

## Researcher papers

- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma](https://scholariq.org/papers/gp100-peptide-vaccine-and-interleukin-2-in-patients-with-advanced-melanoma/)
- [Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-sunitinib-in-first-line-treatment-of/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Providence Portland Medical Center](https://scholariq.org/institutions/providence-portland-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.